Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charlie T Garnett

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
Combination of docetaxel and recombinant vaccine enhances T-cell responses and antitumor activity: effects of docetaxel on immune enhancementCharlie T Garnett, Jeffrey Schlom, James W Hodge
Journal of Immunology (Baltimore, Md. : 1950)|May 10, 2005
Multiple costimulatory modalities enhance CTL avidityJames W Hodge, Mala Chakraborty, Chie Kudo-Saito, et al.
Cancer Immunology, Immunotherapy : CII|May 16, 2007
Intratumoral delivery of vector mediated IL-2 in combination with vaccine results in enhanced T cell avidity and anti-tumor activityChie Kudo-Saito, Charlie T Garnett, Elizabeth K Wansley, et al.
Cancer Research|November 3, 2004
Sublethal irradiation of human tumor cells modulates phenotype resulting in enhanced killing by cytotoxic T lymphocytesCharlie T Garnett, Claudia Palena, Mala Chakraborty, et al.
International Journal of Cancer|February 1, 2013
Chemotherapy-induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell deathJames W Hodge, Charlie T Garnett, Benedetto Farsaci, et al.
Frontiers in Bioscience : a Journal and Virtual Library|June 16, 2007
Synergistic antitumor activity of immune strategies combined with radiationHadley J Sharp, Elizabeth K Wansley, Charlie T Garnett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2006
Combination chemotherapy and radiation of human squamous cell carcinoma of the head and neck augments CTL-mediated lysisAlexander Gelbard, Charlie T Garnett, Scott I Abrams, et al.
Cancer Biotherapy & Radiopharmaceuticals|April 4, 2014
Radiation-induced modulation of costimulatory and coinhibitory T-cell signaling molecules on human prostate carcinoma cells promotes productive antitumor immune interactionsMichael B Bernstein, Charlie T Garnett, Huogang Zhang, et al.
Current Pharmaceutical Design|February 4, 2006
TRICOM vector based cancer vaccinesCharlie T Garnett, John W Greiner, Kwong-Yok Tsang, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
Combination of docetaxel and recombinant vaccine enhances T-cell responses and antitumor activity: effects of docetaxel on immune enhancementCharlie T Garnett, Jeffrey Schlom, James W Hodge
Journal of Immunology (Baltimore, Md. : 1950)|May 10, 2005
Multiple costimulatory modalities enhance CTL avidityJames W Hodge, Mala Chakraborty, Chie Kudo-Saito, et al.
Cancer Immunology, Immunotherapy : CII|May 16, 2007
Intratumoral delivery of vector mediated IL-2 in combination with vaccine results in enhanced T cell avidity and anti-tumor activityChie Kudo-Saito, Charlie T Garnett, Elizabeth K Wansley, et al.
Cancer Research|November 3, 2004
Sublethal irradiation of human tumor cells modulates phenotype resulting in enhanced killing by cytotoxic T lymphocytesCharlie T Garnett, Claudia Palena, Mala Chakraborty, et al.
International Journal of Cancer|February 1, 2013
Chemotherapy-induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell deathJames W Hodge, Charlie T Garnett, Benedetto Farsaci, et al.
Frontiers in Bioscience : a Journal and Virtual Library|June 16, 2007
Synergistic antitumor activity of immune strategies combined with radiationHadley J Sharp, Elizabeth K Wansley, Charlie T Garnett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2006
Combination chemotherapy and radiation of human squamous cell carcinoma of the head and neck augments CTL-mediated lysisAlexander Gelbard, Charlie T Garnett, Scott I Abrams, et al.
Cancer Biotherapy & Radiopharmaceuticals|April 4, 2014
Radiation-induced modulation of costimulatory and coinhibitory T-cell signaling molecules on human prostate carcinoma cells promotes productive antitumor immune interactionsMichael B Bernstein, Charlie T Garnett, Huogang Zhang, et al.
Current Pharmaceutical Design|February 4, 2006
TRICOM vector based cancer vaccinesCharlie T Garnett, John W Greiner, Kwong-Yok Tsang, et al.
Pageof 1